UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells

Journal of the American Chemical Society, 2018-02, Vol.140 (7), p.2478-2484

2018

Volltextzugriff (PDF)

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

PLoS pathogens, 2017-12, Vol.13 (12), p.e1006740-e1006740

2017

Volltextzugriff (PDF)

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie International Edition, 2017-12, Vol.56 (50), p.16023-16027

International ed. in English, 2017

Volltextzugriff (PDF)

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2022-01, Vol.74 (1), p.95-104

2022

Volltextzugriff (PDF)

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro

Journal of neuroinflammation, 2019-09, Vol.16 (1), p.182-182, Article 182

2019

Volltextzugriff (PDF)

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator

Viruses, 2021-01, Vol.13 (1), p.114

2021

Volltextzugriff (PDF)

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections

Viruses, 2024-04, Vol.16 (4), p.651

2024

Volltextzugriff (PDF)

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers

Antimicrobial agents and chemotherapy, 2019-09, Vol.63 (9)

2019

Volltextzugriff (PDF)

Corrigendum: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie International Edition, 2020-07, Vol.59 (31), p.12575-12575

International ed. in English, 2020

Volltextzugriff (PDF)

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Infection and drug resistance, 2014-01, Vol.7 (default), p.41-56

2014

Volltextzugriff (PDF)

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model

Journal of neurovirology, 2020-12, Vol.26 (6), p.838-845

2020

Volltextzugriff (PDF)

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Antimicrobial Agents and Chemotherapy, 2013-03, Vol.57 (3), p.1262-1269

2013

Volltextzugriff (PDF)

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study

Journal of clinical pharmacology, 2021-12, Vol.61 (12), p.1555-1566

2021

Volltextzugriff (PDF)

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

Cancer, 2014-12, Vol.120 (24), p.3940-3951

2014

Volltextzugriff (PDF)

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Cancer prevention research (Philadelphia, Pa.), 2014-03, Vol.7 (3), p.283-291

2014

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

Metabolism open, 2021-06, Vol.10, p.100090-100090, Article 100090

2021

Volltextzugriff (PDF)

Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv

Antiviral therapy, 2012-01, Vol.17 (7), p.1233-1242

2012

Volltextzugriff (PDF)

Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors

Current opinion in HIV & AIDS, 2013-11, Vol.8 (6), p.556-564

2013

Volltextzugriff (PDF)

Randomized, Double-Blind, Multicenter Safety and Efficacy Study of Rifalazil Compared with Azithromycin for Treatment of Uncomplicated Genital Chlamydia trachomatis Infection in Women

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.4014-4019

2014

Volltextzugriff (PDF)

Enhanced Antiretroviral Therapy in Rhesus Macaques Improves RT-SHIV Viral Decay Kinetics

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3927-3933

2014

Volltextzugriff (PDF)

In silico study supports the efficacy of a reduced dose regimen for stavudine

Antiviral research, 2011-11, Vol.92 (2), p.372-377

2011

Volltextzugriff (PDF)

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses

Antiviral research, 2006-09, Vol.71 (2), p.322-334

2006

Volltextzugriff (PDF)

Berichtigung: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Angewandte Chemie, 2020-07, Vol.132 (31), p.12675-12675

2020

Volltextzugriff (PDF)

Practical considerations for developing nucleoside reverse transcriptase inhibitors

Drug discovery today. Technologies, 2012, Vol.9 (3), p.e183-e193

2012

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

Science & Technology
(53)
Life Sciences & Biomedicine
(51)
Humans
(46)
Biological And Medical Sciences
(39)
Medical Sciences
(37)
Pharmacology. Drug Treatments
(29)
Pharmacology & Pharmacy
(26)
Animals
(25)
Antiviral Agents
(25)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(21)
Microbiology
(19)
Female
(18)
Male
(15)
Infectious Diseases
(13)
Hiv
(11)
Macaca Mulatta
(11)
Oncology
(11)
Pharmacokinetics
(11)
Adult
(10)
Antiviral Agents - Pharmacokinetics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Visualization of the Cellular Uptake and Trafficking of DNA Origami Nanostructures in Cancer Cells

Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors

Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Baricitinib reverses HIV-associated neurocognitive disorders in a SCID mouse model and reservoir seeding in vitro

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator

Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers

Corrigendum: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Approaches to hepatitis C treatment and cure using NS5A inhibitors

Novel method to quantify phenotypic markers of HIV-associated neurocognitive disorder in a murine SCID model

Cellular Pharmacology and Potency of HIV-1 Nucleoside Analogs in Primary Human Macrophages

Pharmacokinetics of Ruxolitinib in HIV Suppressed Individuals on Antiretroviral Agent Therapy from the ACTG A5336 Study

Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck

Chemoprevention of Head and Neck Cancer with Celecoxib and Erlotinib: Results of a Phase Ib and Pharmacokinetic Study

Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

Antiretroviral Monocyte Efficacy Score Linked to Cognitive Impairment in Hiv

Prodrug strategies for improved efficacy of nucleoside antiviral inhibitors

Randomized, Double-Blind, Multicenter Safety and Efficacy Study of Rifalazil Compared with Azithromycin for Treatment of Uncomplicated Genital Chlamydia trachomatis Infection in Women

Enhanced Antiretroviral Therapy in Rhesus Macaques Improves RT-SHIV Viral Decay Kinetics

In silico study supports the efficacy of a reduced dose regimen for stavudine

Pharmacology of current and promising nucleosides for the treatment of human immunodeficiency viruses

Berichtigung: Systemic Delivery of Bc12‐Targeting siRNA by DNA Nanoparticles Suppresses Cancer Cell Growth

Practical considerations for developing nucleoside reverse transcriptase inhibitors

Suchergebnisse filtern